Antibody Production Market is Expecting to Accrue Strong Growth in 2025 |Global Key Player - Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Eppendorf AG, Epitomics - an Abcam Company, Roche Molecular Systems, Inc., Enzo Life Sciences
The "Global Antibody Production Market Analysis to 2025" is a specialized and in-depth study of the antibody production industry with a focus on the global market trend. The report aims to provide an overview of global antibody production market with detailed market segmentation by type, device, end user, and geography. The global antibody production market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Get Sample PDF Copy @ http://bit.ly/2QoOEsg
Antibody is also known as immunoglobulin, which is Y-shaped protein that is produced by the immune system to prevent invaders from harming the body. If it is found then the immune system starts producing antibody, which is an invivo process, however the antibody can be created invitro. The antibody production market comprises products that are required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream processing, and filtration.
Leading Key Players
1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. General Electric Company
4. Eppendorf AG
5. Epitomics - an Abcam Company
6. Roche Molecular Systems, Inc.
7. Enzo Life Sciences, Inc.
8. Proteintech Group
9. Bio-Rad Laboratories, Inc.
10. Novus Biologicals
The growth of the antibody production market is driven by the key factors such as increasing funding for the research and development for biopharmaceutical companies. In addition, the regulatory bodies also approve therapeutic antibodies for commercialization. The increase in the infectious diseases are generating opportunities for the antibody producing companies to produce more antibodies for the different antigens.
The antibody production market is segmented based on type as monoclonal antibody and polyclonal antibody. The antibody production market is segmented on the basis of devices as bioreactors, chromatography and consumables. The end user segment is classified as biopharmaceutical/ pharmaceutical companies, research & academic institutes, diagnostic laboratories.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global antibody production market based on instrument, reagent, and software & services. It also provides market size and forecast till 2025 for overall antibody production market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
Buy Complete Report @ http://bit.ly/2PwruLD
North America is expected to be the largest market for the antibody production in the global scenario. Asia Pacific is the fastest growing market for the antibody production market as various technological developments in the healthcare industry and rising research activities. In addition, the company owing patent against antibody creates an opportunity for other company to claim the intellectual property right for similar product.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key antibody production manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.
The Insight partners,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Production Market is Expecting to Accrue Strong Growth in 2025 |Global Key Player - Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Eppendorf AG, Epitomics - an Abcam Company, Roche Molecular Systems, Inc., Enzo Life Sciences here
News-ID: 1427487 • Views: 459
More Releases from The Insight Partners
Subcutaneous Drug Delivery Devices Market to 2027 - Insulet Corporation, BD, Ena …
The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027. The increased number of chronic disease prevalence around the globe, significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, rise in the research and development of new
Aerospace Foam Market 2019 Sales Revenue to Significantly Increase in the Next F …
An Aerospace Foam Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Market by Type, By Application, By Region – North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses
Wood Wax Market 2019 Likely To Experience High Revenue Generation In The Forthco …
An Wood Wax Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Market by Type, By Application, By Region – North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses
Neurometabolic Disorders Market 2019: Trends with Rising Awareness by 2027 - Gre …
Neurometabolic Disorders market is anticipated due to the key driving factors such as rising healthcare expenditures, rising awareness about the diseases, rise in the technological advancement and others. The market is likely to gain growth opportunities owing to the developments in the technologies for genomics that are likely to offer treatments for the rare diseases. The reports cover key developments in the neurometabolic disorders market as organic and inorganic growth strategies.
More Releases for Antibody
Global Antibody Drug Conjugates Market Insights, Forecast
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement
Procalcitonin Antibody Market Opportunity Analysis, 2018 - 2026
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin
Procalcitonin Antibody Market
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E.coli Scope of the Report: This report focuses on the Procalcitonin
Global Combination Antibody Therapy Market | MarketResearchReports.biz
Latest industry research report on: Global Combination Antibody Therapy Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts In its recently published report titled Combination Antibody Therapy Market: Global Industry Analysis and Forecast, 2016-2024, Persistence Market Research reviews the global combination antibody therapy market for an eight year forecast period (2016 2024). This research report provides a detailed analysis of the global combination antibody therapy market
Antibody Drug Conjugate Market Opportunity Analysis
Ever since the first attempt in the 1980's to use antibody-based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the
Global Antibody Drug Conjugate Market & Pipeline Insight2020
Pharmaceutical companies are trying to develop better therapeutics in order to overcome large unmet medical necessities. Currently available therapeutics suffers from various caveats like low specificity, low potency and severe adverse effects. This scenario has caused the pharmaceutical companies to develop therapeutics that can succeed these limitations. They have been able to overcome these problems and improve their medical conditions by commercializing ADC. They are rapidly gaining acceptance across the